Health insurance and accessibility to health services among Roma in settlements in Belgrade, Serbia--the journey from data to policy making.Incidence and survival of central nervous system involvement in childhood malignancies: Hungarian experience.Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase HypersensitivityLate Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFupChildhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.mTOR pathway as a potential target in a subset of human medulloblastoma.Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma.Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care.Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011-2015: Cost-effectiveness analysis.Establishing an internet-based paediatric cancer registration and communication system for the Hungarian paediatric oncology network.Back to basics: the miracle and tragedy of measles vaccine.Tackling tuberculosis: progress made and challenges remaining for the European Union.Smoking and pregnancy.Ten-year experiences on initial genetic examination in childhood acute lymphoblastic leukaemia in Hungary (1993-2002). Technical approaches and clinical implementation.Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?European public health news.Message from the WHO Regional Director for Europe: HIV cases continue to rise in Europe--WHO European Region launches new Action Plan to bring the epidemic under control.[Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe.Health 2020--achieving health and development in today's Europe.High incidence of brain tumors of childhood in Hungary between 1989 and 2001.Zsuzsanna Jakab--director of the European Centre for Disease Prevention and Control. Interview by Pam Das.Trends and territorial inequalities of incidence and survival of childhood leukaemia and their relations to socioeconomic status in Hungary, 1971-2015.The social nature of chronic noncommunicable diseases and how to tackle them through communication technology, training, and outreach.Epidemiologic studies in a population-based childhood cancer registry in Northeast Hungary.Tuberculosis in the European Union: ongoing commitment needed to control the disease.Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy.Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols.Childhood leukaemia incidence in Hungary, 1973-2002. Interpolation model for analysing the possible effects of the Chernobyl accident.The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries.Social determinants of health in EuropeEuropean Public Health NewsEUPHA President's ColumnEUPHA Office ColumnMessage from the WHO Regional Director for EuropeMessage from Vytenis Andriukaitis, EU Commissioner for Health and Food Safety9th European Public Health Conference—‘All for HeaEuropean Public Health NewsEUPHA President's ColumnEUPHA Office columnMessage from the WHO Regional Director for EuropeMessage from Vytenis Andriukaitis, EU Commissioner for Health and Food Safety9th European Public Health Conference—‘All for HeaPrimary health care for the 21st century, universal health coverage, and the Sustainable Development GoalsGood prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy[Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization]Duchenne muscular dystrophy-rhabdomyosarcoma, ichthyosis vulgaris/acute monoblastic leukemia: association of rare genetic disorders and childhood malignant diseases
P50
Q30853814-9EB13AE4-0528-47EA-B490-73895858F69EQ33272284-A7BEA2A1-C705-4A05-B029-60C8A32889AAQ35803355-5040B0AB-D5B0-4246-9EF4-5B04594A0D12Q36137174-19164250-5BAB-4034-BF2F-F61C44C2116CQ38423271-7633D844-DF74-4114-868D-BF4EB16CD290Q39208882-2BB9361F-E254-4F17-99A4-1A06784756C6Q40257977-8D1A921E-49AB-4EAF-866C-F1C66C9490F0Q40956945-1F9F9722-343B-4BAF-AD36-C62F9AAB84B7Q41131199-6A321B21-7A7C-48A7-842C-B8057D11ADF6Q42648251-A654446F-6B1B-4EE4-B850-663B90418935Q43434833-271AB8FC-CBE3-4026-988E-B4A5224479E4Q43476728-644154B0-B41C-42C0-A9B2-AE8E6AA1E444Q43813855-F9886989-1C6F-4D4B-8719-A0294A493C48Q43881991-B92F53F4-6860-4272-B51F-983A0C85F7B5Q44063037-01AB9DBF-8585-4F5C-B0AF-9B72C10C54CBQ44098153-74CF1486-D9B5-45AA-841D-FB5C51891D14Q44667624-FDD02A13-C8EA-4DCF-B05A-FB304E73C8C2Q45277894-E23B260F-DBA0-4A66-94DC-91E2350BE7E0Q45326046-47D427FC-38D7-484F-8617-7463C20DE68DQ46250491-CBE31D2A-3417-4ABC-9231-469D76E481AFQ47428806-F56F3FE3-0D8C-4759-86E0-6768ABE24935Q47676704-A784DD71-7A14-42DD-B523-329E9AD58030Q47728245-6EFE142A-794B-45B2-86E2-13B616010B0FQ48155781-3FBD2593-107D-410C-999D-B4ED5B584763Q48602045-5866C95E-F07F-4FD6-8235-1D42B5E6B7C3Q50525662-1C4476F5-E193-46C8-8FA1-D13183CC9A49Q50608777-63C3ABCD-261B-4B10-B3F5-5C0D8F90AC91Q50694928-09BC9C92-2C80-4EC8-82A3-B89863B12374Q50751107-5E079DF2-5BCE-42D9-86CB-B58665566429Q51464742-A28BA1D2-D7AC-4463-BE1B-FECE97B60EE5Q52926935-85DC0A20-FDCA-484A-8EF5-85421AA84EE9Q53270584-B9DBD2CE-08C3-42BC-B986-82B47550AE4AQ55256588-D66C4BD8-7F03-4885-A067-8CC6E1A05012Q57241354-C367F00F-EC70-4E67-8E87-D49FEBA18D76Q57760696-C3BCC6B1-3206-49F1-BA72-E99897AFC6AEQ57760744-5B3C7F2B-510F-4CF0-AB1C-202FAB02E789Q57808629-D1B23E1B-7B9D-43FE-BF24-6C8FE4DC4F20Q59662732-5CB21D56-CF94-4813-AB19-5E0291425500Q72989643-6B4E0987-6916-451F-BC15-ED3041BDCA9AQ74457281-23E29187-493D-461F-958A-AA22B2719B6A
P50
description
Hongaars epidemiologe
@nl
Hungarian scientist
@en
Hungarian scientist
@en-ca
Hungarian scientist
@en-gb
científica húngara
@es
dirigente pubblico ungherese
@it
eolaí Ungárach
@ga
magyar epidemiológus, államtitkár
@hu
عالمة مجرية
@ar
name
Jakab Zsuzsanna
@hu
Zsuzsanna Jakab
@ast
Zsuzsanna Jakab
@de
Zsuzsanna Jakab
@en
Zsuzsanna Jakab
@es
Zsuzsanna Jakab
@fr
Zsuzsanna Jakab
@ga
Zsuzsanna Jakab
@it
Zsuzsanna Jakab
@nl
Zsuzsanna Jakab
@sl
type
label
Jakab Zsuzsanna
@hu
Zsuzsanna Jakab
@ast
Zsuzsanna Jakab
@de
Zsuzsanna Jakab
@en
Zsuzsanna Jakab
@es
Zsuzsanna Jakab
@fr
Zsuzsanna Jakab
@ga
Zsuzsanna Jakab
@it
Zsuzsanna Jakab
@nl
Zsuzsanna Jakab
@sl
altLabel
Zsuzsanna Jakab
@sq
dr. Jakab Ferencné
@hu
prefLabel
Jakab Zsuzsanna
@hu
Zsuzsanna Jakab
@ast
Zsuzsanna Jakab
@de
Zsuzsanna Jakab
@en
Zsuzsanna Jakab
@es
Zsuzsanna Jakab
@fr
Zsuzsanna Jakab
@ga
Zsuzsanna Jakab
@it
Zsuzsanna Jakab
@nl
Zsuzsanna Jakab
@sl
P106
P1412
P69
P1417
biography/Zsuzsanna-Jakab
P19
P21
P214
8355150470103804330000
P27
P31
P3973
PIM1946076
P569
1951-05-17T00:00:00Z